Is Velan Stock a Buy at 52-Week Highs?

Velan stock just surged by 30% in share price after stellar third-quarter earnings, but is the stock now still a buy?

| More on:

Velan (TSX:VLN) recently caught the attention of investors, surging in share price by 30% this week on stellar third-quarter results. This dramatic rise reflects market confidence in the company’s strategic direction and recent financial performance. Let’s dive deeper into its earnings, past performance, future outlook, and whether the stock deserves its current momentum or not.

Confused person shrugging

Source: Getty Images

Into earnings

Velan reported sales of $73.4 million in the third quarter (Q3), an 18.1% year-over-year increase driven by strong shipments from its Italian operations for oil and gas markets and the petrochemical sector in China. The gross profit soared to $28.3 million, or 38.6% of sales, compared to $8.2 million (13.1% of sales) last year, reflecting efficiency gains, a favourable product mix, and reduced exposure to problematic contracts.

Adjusted net income from continuing operations reached $8.5 million or $0.39 per share, a stark improvement from a $7.0 million adjusted net loss of $0.32 per share in Q3 2024. This turnaround was primarily attributed to higher sales volumes and gross profit. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) also jumped significantly to $14.3 million. Compared to negative $4.1 million last year, showcasing Velan’s enhanced operational efficiency.

However, the company recorded a net loss of $47.8 million, largely due to one-time restructuring costs of $74.5 million related to the divestiture of asbestos liabilities. Excluding these costs, the company’s adjusted financials demonstrate a much healthier position.

Growing strength

Velan stock’s recent announcement to divest its asbestos-related liabilities is a game-changer. By transferring its liabilities to a subsidiary and selling it to Global Risk Capital, Velan effectively removes significant legacy risks. This transaction, though expensive upfront at $143 million, clears its balance sheet of a major drag and indemnifies the company from future asbestos-related obligations.

Furthermore, Velan stock’s order backlog grew by 5.3% since the start of the fiscal year. Now reaching $298.7 million, with $249.1 million (83.4%) expected to be delivered within the next 12 months. This backlog, combined with recent nuclear energy initiatives, positions Velan stock to capitalize on global clean energy trends. Including opportunities in small modular reactors and life-extension projects for existing nuclear facilities.

Despite slightly lower bookings for the quarter to $59.1 million compared to $60.1 million last year, the nine-month total bookings of $230.5 million mark a significant 30% increase year over year. This reflects Velan stock’s growing relevance in markets like North America and Germany, though challenges remain in regions like Italy.

What to consider

Velan stock reinstated a quarterly dividend of $0.03 per share, reflecting management’s confidence in the company’s financial stability and future growth prospects. While the payout is modest, it signals a commitment to shareholder returns, with a potential for increases post-transaction closings. The company’s net cash position of $32.1 million and manageable long-term debt of $19.5 million suggest a stable financial foundation.

While Velan stock’s underlying business is improving, the stock is not without risks. The company’s restructuring costs have led to significant headline losses, which may deter risk-averse investors. The book-to-bill ratio of 0.81 for the quarter reflects a slight decline in order replenishment rates, though the nine-month ratio of 1.09 suggests strong overall demand. Investors should also monitor currency fluctuations, which have had minor but measurable impacts on the company’s financials.

Bottom line

Velan stock’s Q3 results and strategic initiatives paint a picture of a company in transition but on a promising path. The surge in gross profit, significant backlog, and targeted divestitures indicate a company strengthening its core business while addressing past liabilities. The reinstatement of a dividend adds further confidence in its trajectory.

However, Velan stock’s recent 30% surge may have already priced in much of this optimism. Investors looking for long-term growth, particularly in the clean energy sector, may find Velan stock appealing. For others, waiting for further clarity on transaction outcomes or a potential dip in share price could present a better entry point. So, Velan stock appears to be a calculated but potentially rewarding buy for investors comfortable with some short-term volatility — all in exchange for exposure to a turnaround story with long-term growth prospects.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Dividend Stocks

young people dance to exercise
Dividend Stocks

30-Year-Olds: Stop What You’re Doing and Start Your TFSA Catch up

A lot of Canadians in their 30s have plenty of TFSA room left, and a small-cap like Rubellite is the…

Read more »

A worker drinks out of a mug in an office.
Dividend Stocks

1 Incredible TSX Dividend Stock to Buy While It’s Down 50%

This unloved stock could bounce in the coming weeks.

Read more »

senior man and woman stretch their legs on yoga mats outside
Dividend Stocks

A Canadian Dividend Stock Down 35% to Buy and Hold for Retirement

Stantec stock has fallen 34% from its high. Here's why this fast-growing Canadian dividend payer looks like a buy-and-hold for…

Read more »

three friends eat pizza
Dividend Stocks

How Much Should a 20-Year-Old Canadian Have in Their TFSA to Retire?

Starting early and aiming to max TFSA contributions to allow for decades of tax‑free compounding matter more than any specific…

Read more »

Printing canadian dollar bills on a print machine
Dividend Stocks

How to Turn a $14,000 TFSA Into a Cash Generating Machine

Two blue chip pipeline stocks quietly pay you to do nothing. Here is the simple math that TFSA investors should…

Read more »

chart reflected in eyeglass lenses
Top TSX Stocks

5 Cheap Canadian Stocks to Buy Before the Market Notices

Explore five cheap Canadian stocks that remain overlooked and may offer strong long‑term upside as fundamentals improve.

Read more »

Nuclear power station cooling tower
Dividend Stocks

1 Magnificent TSX Dividend Stock Down 20% to Buy and Hold For Decades

This infrastructure builder just posted record numbers, yet the market is treating it like an afterthought.

Read more »

dividends grow over time
Dividend Stocks

1 Dividend Stock That’s Been Quietly, But Constantly, Raising Its Dividend

Chemtrade’s monthly distribution has been climbing, and its cash-flow coverage suggests the payout isn’t just a headline.

Read more »